menu
    • menu

    Company profile for Arrivo BioVentures

    NEW Drugs in Dev: 2
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Arrivo, we strive to set a new standard in drug development that starts with the selection of drug candidates and runs throughout clinical development. Our approach and decision-making has delivered a history of excellent returns and product successes that makes us the trusted partner for industry and investors.Working in partnership with investors, innovators, and pharmaceutical companies, Arrivo is always seeking out solu...
    At Arrivo, we strive to set a new standard in drug development that starts with the selection of drug candidates and runs throughout clinical development. Our approach and decision-making has delivered a history of excellent returns and product successes that makes us the trusted partner for industry and investors.Working in partnership with investors, innovators, and pharmaceutical companies, Arrivo is always seeking out solutions for unmet medical needs. We strive to be the new standard for strategic asset selection and develop novel products through process that is both highly efficient and thoughtful.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Arrivo BioVenturesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9001 Aerial Center Parkway, Suite 110 Morrisville, NC 27560-9731
    Telephone
    Telephone
    919.460.9500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://arrivobio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/arrivo-bioventures-llc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arrivo BioVentures Starts Ph 1 Of SP-624 For Women's Major Depression
    Arrivo BioVentures Starts Ph 1 Of SP-624 For Women's Major Depression

    10 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241010025985/en

    BUSINESSWIRE
    10 Oct 2024
    Share Share
    Arrivo's RABI-767 For Acute Pancreatitis Receives FDA Fast Track Status
    Arrivo's RABI-767 For Acute Pancreatitis Receives FDA Fast Track Status

    15 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240715136157/en

    BUSINESSWIRE
    15 Jul 2024
    Share Share
    Arrivo Bio Initiates Large Phase 2b Trial For MDD SIRT6 Activator
    Arrivo Bio Initiates Large Phase 2b Trial For MDD SIRT6 Activator

    16 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240416487796/en

    BUSINESSWIRE
    16 Apr 2024
    Share Share
    Arrivo bags $45M Series B to fund major depression late-stage test
    Arrivo bags $45M Series B to fund major depression late-stage test

    29 Nov 2023

    // Ayisha Sharma ENDPTS

    https://endpts.com/arrivo-bags-45m-series-b-to-fund-major-depression-late-stage-test-and-phii-ready-pancreatitis-asset/

    Ayisha Sharma ENDPTS
    29 Nov 2023
    Share Share
    Arrivo's depression med flunks ph. 2, shows benefit for women
    Arrivo's depression med flunks ph. 2, shows benefit for women

    17 Oct 2022

    // Max Bayer FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/arrivo-flunks-phase-2-trial-its-depression-med-touts-benefit-seen-specifically-women

    Max Bayer FIERCEBIOTECH
    17 Oct 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search